Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women

Pauline M. Maki, Leah H. Rubin, Mardge Cohen, Elizabeth T. Golub, Ruth M. Greenblatt, Mary Young, Rebecca M. Schwartz, Kathryn Anastos, Judith A. Cook

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

OBJECTIVE: The risk of clinically significant depressive symptoms increases during perimenopause. With highly active antiretroviral treatment (HAART), more human immunodeficiency virus (HIV)-infected women survive to transition through menopause. In a cross-sectional analysis, we evaluated the association of menopausal stage and vasomotor symptoms with depressive symptoms in an ethnically diverse cohort of women with a high prevalence of HIV. METHODS: Participants included 835 HIV-infected women and 335 HIV-uninfected controls from the Women's Interagency HIV Study (63% African American). The Center for Epidemiologic Studies Depression Scale was used to screen for elevated depressive symptoms. Menopausal stages were defined according to standard definitions. Logistic regression analysis was used to identify predictors of elevated depressive symptoms. RESULTS: Compared with premenopausal women, early perimenopausal women (OR [odds ratio], 1.74; 95% CI, 1.17-2.60), but not late perimenopausal or postmenopausal women, were more likely to show elevated depressive symptoms in adjusted analyses. The odds were similar in HIV-infected and HIV-uninfected women. Persistent vasomotor symptoms also predicted elevated depressive symptoms in HIV-infected and HIV-uninfected women (OR, 1.45; 95% CI, 1.02-2.06). In HIV-infected women, menopausal stage interacted with antiretroviral use (P = 0.02); the likelihood of elevated depressive symptoms in early perimenopause compared with premenopause was especially high in HAART-untreated women (OR, 3.87; 95% CI, 1.57-9.55). CONCLUSIONS: In HIV-infected and HIV-uninfected women, the odds of elevated depressive symptoms were significantly higher during early perimenopause. Elevated depressive symptoms were associated with nonadherence to HAART, underscoring the importance of screening and treating depressive symptoms in HIV-infected women who have experienced a change in the regularity of their menstrual cycles.

Original languageEnglish (US)
Pages (from-to)1215-1223
Number of pages9
JournalMenopause
Volume19
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

HIV
Depression
Perimenopause
Premenopause
Menstrual Cycle
Menopause
African Americans
Epidemiologic Studies
Therapeutics
Cross-Sectional Studies
Logistic Models
Odds Ratio
Regression Analysis

Keywords

  • African American
  • Depression
  • HIV
  • Menopause
  • Perimenopause
  • Vasomotor

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. / Maki, Pauline M.; Rubin, Leah H.; Cohen, Mardge; Golub, Elizabeth T.; Greenblatt, Ruth M.; Young, Mary; Schwartz, Rebecca M.; Anastos, Kathryn; Cook, Judith A.

In: Menopause, Vol. 19, No. 11, 11.2012, p. 1215-1223.

Research output: Contribution to journalArticle

Maki, Pauline M. ; Rubin, Leah H. ; Cohen, Mardge ; Golub, Elizabeth T. ; Greenblatt, Ruth M. ; Young, Mary ; Schwartz, Rebecca M. ; Anastos, Kathryn ; Cook, Judith A. / Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. In: Menopause. 2012 ; Vol. 19, No. 11. pp. 1215-1223.
@article{5ea0172825e749f99aeb3fbcfd19a882,
title = "Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women",
abstract = "OBJECTIVE: The risk of clinically significant depressive symptoms increases during perimenopause. With highly active antiretroviral treatment (HAART), more human immunodeficiency virus (HIV)-infected women survive to transition through menopause. In a cross-sectional analysis, we evaluated the association of menopausal stage and vasomotor symptoms with depressive symptoms in an ethnically diverse cohort of women with a high prevalence of HIV. METHODS: Participants included 835 HIV-infected women and 335 HIV-uninfected controls from the Women's Interagency HIV Study (63{\%} African American). The Center for Epidemiologic Studies Depression Scale was used to screen for elevated depressive symptoms. Menopausal stages were defined according to standard definitions. Logistic regression analysis was used to identify predictors of elevated depressive symptoms. RESULTS: Compared with premenopausal women, early perimenopausal women (OR [odds ratio], 1.74; 95{\%} CI, 1.17-2.60), but not late perimenopausal or postmenopausal women, were more likely to show elevated depressive symptoms in adjusted analyses. The odds were similar in HIV-infected and HIV-uninfected women. Persistent vasomotor symptoms also predicted elevated depressive symptoms in HIV-infected and HIV-uninfected women (OR, 1.45; 95{\%} CI, 1.02-2.06). In HIV-infected women, menopausal stage interacted with antiretroviral use (P = 0.02); the likelihood of elevated depressive symptoms in early perimenopause compared with premenopause was especially high in HAART-untreated women (OR, 3.87; 95{\%} CI, 1.57-9.55). CONCLUSIONS: In HIV-infected and HIV-uninfected women, the odds of elevated depressive symptoms were significantly higher during early perimenopause. Elevated depressive symptoms were associated with nonadherence to HAART, underscoring the importance of screening and treating depressive symptoms in HIV-infected women who have experienced a change in the regularity of their menstrual cycles.",
keywords = "African American, Depression, HIV, Menopause, Perimenopause, Vasomotor",
author = "Maki, {Pauline M.} and Rubin, {Leah H.} and Mardge Cohen and Golub, {Elizabeth T.} and Greenblatt, {Ruth M.} and Mary Young and Schwartz, {Rebecca M.} and Kathryn Anastos and Cook, {Judith A.}",
year = "2012",
month = "11",
doi = "10.1097/gme.0b013e318255434d",
language = "English (US)",
volume = "19",
pages = "1215--1223",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women

AU - Maki, Pauline M.

AU - Rubin, Leah H.

AU - Cohen, Mardge

AU - Golub, Elizabeth T.

AU - Greenblatt, Ruth M.

AU - Young, Mary

AU - Schwartz, Rebecca M.

AU - Anastos, Kathryn

AU - Cook, Judith A.

PY - 2012/11

Y1 - 2012/11

N2 - OBJECTIVE: The risk of clinically significant depressive symptoms increases during perimenopause. With highly active antiretroviral treatment (HAART), more human immunodeficiency virus (HIV)-infected women survive to transition through menopause. In a cross-sectional analysis, we evaluated the association of menopausal stage and vasomotor symptoms with depressive symptoms in an ethnically diverse cohort of women with a high prevalence of HIV. METHODS: Participants included 835 HIV-infected women and 335 HIV-uninfected controls from the Women's Interagency HIV Study (63% African American). The Center for Epidemiologic Studies Depression Scale was used to screen for elevated depressive symptoms. Menopausal stages were defined according to standard definitions. Logistic regression analysis was used to identify predictors of elevated depressive symptoms. RESULTS: Compared with premenopausal women, early perimenopausal women (OR [odds ratio], 1.74; 95% CI, 1.17-2.60), but not late perimenopausal or postmenopausal women, were more likely to show elevated depressive symptoms in adjusted analyses. The odds were similar in HIV-infected and HIV-uninfected women. Persistent vasomotor symptoms also predicted elevated depressive symptoms in HIV-infected and HIV-uninfected women (OR, 1.45; 95% CI, 1.02-2.06). In HIV-infected women, menopausal stage interacted with antiretroviral use (P = 0.02); the likelihood of elevated depressive symptoms in early perimenopause compared with premenopause was especially high in HAART-untreated women (OR, 3.87; 95% CI, 1.57-9.55). CONCLUSIONS: In HIV-infected and HIV-uninfected women, the odds of elevated depressive symptoms were significantly higher during early perimenopause. Elevated depressive symptoms were associated with nonadherence to HAART, underscoring the importance of screening and treating depressive symptoms in HIV-infected women who have experienced a change in the regularity of their menstrual cycles.

AB - OBJECTIVE: The risk of clinically significant depressive symptoms increases during perimenopause. With highly active antiretroviral treatment (HAART), more human immunodeficiency virus (HIV)-infected women survive to transition through menopause. In a cross-sectional analysis, we evaluated the association of menopausal stage and vasomotor symptoms with depressive symptoms in an ethnically diverse cohort of women with a high prevalence of HIV. METHODS: Participants included 835 HIV-infected women and 335 HIV-uninfected controls from the Women's Interagency HIV Study (63% African American). The Center for Epidemiologic Studies Depression Scale was used to screen for elevated depressive symptoms. Menopausal stages were defined according to standard definitions. Logistic regression analysis was used to identify predictors of elevated depressive symptoms. RESULTS: Compared with premenopausal women, early perimenopausal women (OR [odds ratio], 1.74; 95% CI, 1.17-2.60), but not late perimenopausal or postmenopausal women, were more likely to show elevated depressive symptoms in adjusted analyses. The odds were similar in HIV-infected and HIV-uninfected women. Persistent vasomotor symptoms also predicted elevated depressive symptoms in HIV-infected and HIV-uninfected women (OR, 1.45; 95% CI, 1.02-2.06). In HIV-infected women, menopausal stage interacted with antiretroviral use (P = 0.02); the likelihood of elevated depressive symptoms in early perimenopause compared with premenopause was especially high in HAART-untreated women (OR, 3.87; 95% CI, 1.57-9.55). CONCLUSIONS: In HIV-infected and HIV-uninfected women, the odds of elevated depressive symptoms were significantly higher during early perimenopause. Elevated depressive symptoms were associated with nonadherence to HAART, underscoring the importance of screening and treating depressive symptoms in HIV-infected women who have experienced a change in the regularity of their menstrual cycles.

KW - African American

KW - Depression

KW - HIV

KW - Menopause

KW - Perimenopause

KW - Vasomotor

UR - http://www.scopus.com/inward/record.url?scp=84868677893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868677893&partnerID=8YFLogxK

U2 - 10.1097/gme.0b013e318255434d

DO - 10.1097/gme.0b013e318255434d

M3 - Article

C2 - 22872013

AN - SCOPUS:84868677893

VL - 19

SP - 1215

EP - 1223

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 11

ER -